Ross W. Stephens

5.7k total citations
102 papers, 4.6k citations indexed

About

Ross W. Stephens is a scholar working on Cancer Research, Hematology and Oncology. According to data from OpenAlex, Ross W. Stephens has authored 102 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cancer Research, 38 papers in Hematology and 36 papers in Oncology. Recurrent topics in Ross W. Stephens's work include Protease and Inhibitor Mechanisms (68 papers), Blood Coagulation and Thrombosis Mechanisms (34 papers) and Cell Adhesion Molecules Research (29 papers). Ross W. Stephens is often cited by papers focused on Protease and Inhibitor Mechanisms (68 papers), Blood Coagulation and Thrombosis Mechanisms (34 papers) and Cell Adhesion Molecules Research (29 papers). Ross W. Stephens collaborates with scholars based in Finland, Australia and Denmark. Ross W. Stephens's co-authors include Antti Vaheri, J Pöllänen, Keld Danø, Nils Brünner, Hans Jørgen Nielsen, Hannele Tapiovaara, Gunilla Høyer‐Hansen, Eija Salonen, Ebbe Rønne and Niels Behrendt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Ross W. Stephens

102 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross W. Stephens Finland 38 2.9k 1.6k 1.4k 1.3k 1.0k 102 4.6k
S M Wilhelm United States 19 3.4k 1.1× 1.3k 0.8× 2.1k 1.5× 1.7k 1.2× 883 0.9× 24 5.5k
Barry L. Marmer United States 16 4.6k 1.6× 1.8k 1.1× 2.7k 2.0× 1.7k 1.2× 1.2k 1.2× 17 6.1k
Milagros Balbı́n Spain 38 2.5k 0.9× 687 0.4× 1.8k 1.4× 2.1k 1.6× 687 0.7× 71 5.3k
P.A. Andreasen Denmark 31 5.1k 1.7× 3.1k 1.9× 1.6k 1.2× 2.6k 1.9× 1.7k 1.7× 48 7.3k
Tze-Chein Wun United States 26 1.8k 0.6× 1.7k 1.1× 451 0.3× 945 0.7× 515 0.5× 51 3.2k
Kazushi Imai Japan 30 2.1k 0.7× 624 0.4× 1.4k 1.1× 1.5k 1.1× 686 0.7× 70 4.2k
Boye Schnack Nielsen Denmark 44 3.1k 1.1× 688 0.4× 1.5k 1.1× 2.7k 2.0× 791 0.8× 119 5.5k
Egbert K. O. Kruithof Switzerland 43 2.1k 0.7× 1.9k 1.2× 373 0.3× 1.4k 1.0× 726 0.7× 102 4.9k
Alicia G. Arroyo Spain 41 1.5k 0.5× 750 0.5× 1.2k 0.9× 1.8k 1.4× 1.7k 1.7× 74 5.0k
Cornelis F.M. Sier Netherlands 43 2.0k 0.7× 560 0.4× 2.1k 1.6× 1.9k 1.4× 523 0.5× 130 5.4k

Countries citing papers authored by Ross W. Stephens

Since Specialization
Citations

This map shows the geographic impact of Ross W. Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross W. Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross W. Stephens more than expected).

Fields of papers citing papers by Ross W. Stephens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross W. Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross W. Stephens. The network helps show where Ross W. Stephens may publish in the future.

Co-authorship network of co-authors of Ross W. Stephens

This figure shows the co-authorship network connecting the top 25 collaborators of Ross W. Stephens. A scholar is included among the top collaborators of Ross W. Stephens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross W. Stephens. Ross W. Stephens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Høgdall, Claus, Ib Jarle Christensen, Ross W. Stephens, et al.. (2002). Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI‐1 and serum CEA. Apmis. 110(9). 630–638. 14 indexed citations
2.
Riisbro, Rikke, Ross W. Stephens, Nils Brünner, et al.. (2001). Soluble Urokinase Plasminogen Activator Receptor in Preoperatively Obtained Plasma from Patients with Gynecological Cancer or Benign Gynecological Diseases. Gynecologic Oncology. 82(3). 523–531. 32 indexed citations
3.
Bjerregaard, Simon, Ross W. Stephens, Leif R. Lund, et al.. (2001). Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin. Journal of Controlled Release. 71(1). 87–98. 30 indexed citations
4.
5.
Høyer‐Hansen, Gunilla, Maria J. A. G. Hamers, Anders N. Pedersen, et al.. (2000). Loss of ELISA specificity due to biotinylation of monoclonal antibodies. Journal of Immunological Methods. 235(1-2). 91–99. 35 indexed citations
6.
Slot, Ole, N. Brünner, Henning Locht, P. Oxholm, & Ross W. Stephens. (1999). Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Annals of the Rheumatic Diseases. 58(8). 488–492. 114 indexed citations
7.
Stephens, Ross W.. (1999). Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis. JNCI Journal of the National Cancer Institute. 91(10). 869–874. 249 indexed citations
8.
Holten-Andersen, Mads, Gillian Murphy, Hans Jørgen Nielsen, et al.. (1999). Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. British Journal of Cancer. 80(3-4). 495–503. 128 indexed citations
9.
Örning, Lars, Ross W. Stephens, Lizette B. Petersen, et al.. (1997). A PEPTIDE SEQUENCE FROM THE EGF-2 LIKE DOMAIN OF FVII INHIBITS TF-DEPENDENT FX ACTIVATION.. Thrombosis Research. 86(1). 57–67. 10 indexed citations
10.
Stephens, Ross W., et al.. (1992). Cell surface plasminogen activation and leukemia. Fibrinolysis & proteolysis. 4. 35–39. 6 indexed citations
11.
Sirén, Vappu, Ross W. Stephens, Eeva‐Marjatta Salonen, et al.. (1992). Retinal Pigment Epithelial Cells Secrete Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1. Ophthalmic Research. 24(4). 203–212. 19 indexed citations
12.
Stephens, Ross W., et al.. (1992). Urokinase binding to laminin‐nidogen. European Journal of Biochemistry. 207(3). 937–942. 22 indexed citations
13.
Stephens, Ross W., et al.. (1992). Heparin binding to the urokinase kringle domain. Biochemistry. 31(33). 7572–7579. 87 indexed citations
14.
Stephens, Ross W., et al.. (1991). Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells.. PubMed. 2(12). 1057–1065. 17 indexed citations
15.
16.
Setten, G.‐B. van, Ross W. Stephens, Timo Tervo, et al.. (1990). Effects of the Schirmer test on the fibrinolytic system in the tear fluid. Experimental Eye Research. 50(2). 135–141. 29 indexed citations
17.
Neuman, Toomas, Ross W. Stephens, Eija Salonen, Tõnis Timmusk, & Antti Vaheri. (1989). Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue‐type plasminogen activator. Journal of Neuroscience Research. 23(3). 274–281. 56 indexed citations
18.
Salonen, Eija, J. Lauharanta, P S Sim, Ross W. Stephens, & Antti Vaheri. (1988). Rapid appearance of plasmin in tear fluid after ocular allergen exposure.. PubMed Central. 73(1). 146–8. 21 indexed citations
19.
Sim, P S, Ross W. Stephens, D R Fayle, & William F. Doe. (1988). Urokinase‐type plasminogen activator in colorectal carcinomas and adenomatous polyps: Quantitative expression of active and proenzyme. International Journal of Cancer. 42(4). 483–488. 39 indexed citations
20.
Sim, P S, D R Fayle, William F. Doe, & Ross W. Stephens. (1986). Monoclonal antibodies inhibitory to human plasmin. European Journal of Biochemistry. 158(3). 537–542. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S M Wilhelm Breakdown of academic impact, for papers by Barry L. Marmer Breakdown of academic impact, for papers by Milagros Balbı́n Breakdown of academic impact, for papers by P.A. Andreasen Breakdown of academic impact, for papers by Tze-Chein Wun Breakdown of academic impact, for papers by Kazushi Imai Breakdown of academic impact, for papers by Boye Schnack Nielsen Breakdown of academic impact, for papers by Egbert K. O. Kruithof Breakdown of academic impact, for papers by Alicia G. Arroyo Breakdown of academic impact, for papers by Cornelis F.M. Sier
Rankless by CCL
2026